Epidemiologic Relationship Between Fuchs Heterochromic Iridocyclitis and the United States Rubella Vaccination Program

American Journal of Ophthalmology

Volumn 144, Issue 3, 2007, Pages

  Birnbaum, Andrea D ^a   Tessler, Howard H ^a   Schultz, Kara L ^a   Farber, Marilyn D ^b   Gao, Weihua ^a   Lin, Phoebe ^a   Oh, Frederick ^c   Goldstein, Debra A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois School of Public Health ^*

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA VACCINE;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRANULOMATOSIS; HEALTH PROGRAM; HUMAN; IDIOPATHIC DISEASE; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED STATES;

EID: 34548261247     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.05.026     Document Type: Article

References (15)

1. Tran V.T., Auer C., Guex-Crosier Y., et al. Epidemiological characterization of uveitis in Switzerland. Int Ophthalmol 18 (1994) 293-298
2. Franceschetti A. Heterochromic cyclitis: Fuchs' syndrome. Am J Ophthalmol 39 (1955) 50-58
3. Kimura S.J., Hogan M.J., and Thygeson P. Fuchs' syndrome of heterochromic cyclitis. AMA Arch Ophthalmol 54 (1955) 179-186
4. Mohamed Q., and Zamir E. Update on Fuchs' uveitis syndrome. Curr Opin Ophthalmol 16 (2005) 356-363
5. O'Conner G.R. Doyne Lecture. Heterochromic iridocyclitis. Trans Ophthalmol Soc UK 104 (1985) 219-231
6. Quentin C.D., and Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138 (2004) 46-54
7. de Groot-Mijnes J.D., de Visser L., Rothova A., et al. Rubella virus is associated with Fuchs heterochromic iridocyclitis. Am J Ophthalmol 141 (2006) 212-214
8. Preblud S.R., Serdula M.K., Frank Jr. J.A., et al. From the Center for Disease Control: current status of rubella in the United States, 1969-1979. J Infect Dis 142 (1980) 776-779
9. Williams N.M., and Preblud S.R. Rubella and congenital rubella surveillance. 1983. MMWR CDC Surveill Summ 33 (1984) 1SS-10SS
10. The Centers for Disease Control and Prevention (CDC). Elimination of rubella and congenital rubella syndrome-United States, 1969-2004. MMWR Morb Mortal Wkly Rep 54 (2005) 279-282
11. Hinman A.R., Preblud S.R., and Brandling-Bennett A.D. Rubella: the U.S. experience. Dev Biol Stand 43 (1979) 315-326
12. Reef S.E., Frey T.K., Theall K., et al. The changing epidemiology of rubella in the 1990s. On the verge of elimination and new changes for control and prevention. JAMA 287 (2002) 464-472
13. The Centers for Disease Control and Prevention. Measles, rubella and congenital rubella syndrome-United States and Mexico, 1997-1999. MMWR Morb Mortal Wkly Rep 49 (2000) 1048-1059
14. World Health Organization Department of Vaccines and Biologicals. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance need. Meeting on preventing CRS, January, 2000. Available at www.vaccines.who.int/vaccines-documents/. Accessed Date: April 29, 2007.
15. Johnson C.E., Kumar M.L., Whitwell J.K., et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs eleven to thirteen years. Pediatri Infect Dis J 15 (1996) 687-692